Since AIs substantially reduced the estrogen degree in women just after menopause, they may bring about bone thinning, from time to time leading to osteoporosis and even fractures.Development taking place six or even more months right after initiating the initial endocrine therapy for metastatic condition (either fulvestrant or aromatase inhibitor